Literature DB >> 32298791

Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.

Apurba Bhattarai1, Jinan Wang1, Yinglong Miao2.   

Abstract

BACKGROUND: Ensemble docking has proven useful in drug discovery and development. It increases the hit rate by incorporating receptor flexibility into molecular docking as demonstrated on important drug targets including G-protein-coupled receptors (GPCRs). Adenosine A1 receptor (A1AR) is a key GPCR that has been targeted for treating cardiac ischemia-reperfusion injuries, neuropathic pain and renal diseases. Development of allosteric modulators, compounds binding to distinct and less conserved GPCR target sites compared with agonists and antagonists, has attracted increasing interest for designing selective drugs of the A1AR. Despite significant advances, more effective approaches are needed to discover potent and selective allosteric modulators of the A1AR.
METHODS: Ensemble docking that integrates Gaussian accelerated molecular dynamic (GaMD) simulations and molecular docking using Autodock has been implemented for retrospective docking of known positive allosteric modulators (PAMs) in the A1AR.
RESULTS: Ensemble docking outperforms docking of the receptor cryo-EM structure. The calculated docking enrichment factors (EFs) and the area under the receiver operating characteristic curves (AUC) are significantly increased.
CONCLUSIONS: Receptor ensembles generated from GaMD simulations are able to increase the success rate of discovering PAMs of A1AR. It is important to account for receptor flexibility through GaMD simulations and flexible docking. GENERAL SIGNIFICANCE: Ensemble docking is a promising approach for drug discovery targeting flexible receptors.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine A(1) receptor; Allosteric modulators; Ensemble docking; G-protein-coupled receptors; Gaussian accelerated molecular dynamics

Mesh:

Substances:

Year:  2020        PMID: 32298791      PMCID: PMC7261249          DOI: 10.1016/j.bbagen.2020.129615

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  64 in total

Review 1.  Flexible receptor docking for drug discovery.

Authors:  Chung F Wong
Journal:  Expert Opin Drug Discov       Date:  2015-08-26       Impact factor: 6.098

2.  Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Adriaan P IJzerman; Arnault Massink; Olga Cruz-Lopez; Luisa Carlota Lopez-Cara; Giulia Saponaro; Delia Preti; Mojgan Aghazadeh Tabrizi; Stefania Baraldi; Allan R Moorman; Fabrizio Vincenzi; Pier Andrea Borea; Katia Varani
Journal:  J Med Chem       Date:  2014-09-12       Impact factor: 7.446

3.  Gaussian Accelerated Molecular Dynamics: Theory, Implementation, and Applications.

Authors:  Yinglong Miao; J Andrew McCammon
Journal:  Annu Rep Comput Chem       Date:  2017-08-10

4.  2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.

Authors:  C Elisabet Tranberg; Andrea Zickgraf; Brian N Giunta; Henning Luetjens; Heidi Figler; Lauren J Murphree; Ruediger Falke; Holger Fleischer; Joel Linden; Peter J Scammells; Ray A Olsson
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

5.  Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.

Authors:  P G Baraldi; A N Zaid; I Lampronti; F Fruttarolo; M G Pavani; M A Tabrizi; J C Shryock; E Leung; R Romagnoli
Journal:  Bioorg Med Chem Lett       Date:  2000-09-04       Impact factor: 2.823

6.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

7.  AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility.

Authors:  Pradeep Anand Ravindranath; Stefano Forli; David S Goodsell; Arthur J Olson; Michel F Sanner
Journal:  PLoS Comput Biol       Date:  2015-12-02       Impact factor: 4.475

8.  Acceleration of biomolecular kinetics in Gaussian accelerated molecular dynamics.

Authors:  Yinglong Miao
Journal:  J Chem Phys       Date:  2018-08-21       Impact factor: 3.488

9.  Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation.

Authors:  Yinglong Miao; Victoria A Feher; J Andrew McCammon
Journal:  J Chem Theory Comput       Date:  2015-07-14       Impact factor: 6.006

Review 10.  Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor.

Authors:  Kalli Kappel; Yinglong Miao; J Andrew McCammon
Journal:  Q Rev Biophys       Date:  2015-11       Impact factor: 5.318

View more
  4 in total

1.  Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery.

Authors:  Kyle McKay; Nicholas B Hamilton; Jacob M Remington; Severin T Schneebeli; Jianing Li
Journal:  Front Mol Biosci       Date:  2022-06-29

2.  Gaussian accelerated molecular dynamics (GaMD): principles and applications.

Authors:  Jinan Wang; Pablo R Arantes; Apurba Bhattarai; Rohaine V Hsu; Shristi Pawnikar; Yu-Ming M Huang; Giulia Palermo; Yinglong Miao
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2021-03-01

Review 3.  Molecular Simulations and Drug Discovery of Adenosine Receptors.

Authors:  Jinan Wang; Apurba Bhattarai; Hung N Do; Sana Akhter; Yinglong Miao
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

Review 4.  From Data to Knowledge: Systematic Review of Tools for Automatic Analysis of Molecular Dynamics Output.

Authors:  Hanna Baltrukevich; Sabina Podlewska
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.